These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 10571771)

  • 21. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA; da Silva CG; Costa RS; Coimbra TM
    Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
    Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
    Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trophic factors and cytokines in early diabetic glomerulopathy.
    Brosius FC
    Exp Diabesity Res; 2003; 4(4):225-33. PubMed ID: 14668046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research into the glomerular podocyte--is it relevant to diabetic nephropathy?
    White KE
    Diabet Med; 2006 Jul; 23(7):715-9. PubMed ID: 16842474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.
    Ziyadeh FN
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S38-41. PubMed ID: 18842317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of interstitial fibrosis in obstructive nephropathy.
    Diamond JR; Ricardo SD; Klahr S
    Semin Nephrol; 1998 Nov; 18(6):594-602. PubMed ID: 9819150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy.
    Ina K; Kitamura H; Tatsukawa S; Takayama T; Fujikura Y; Shimada T
    Med Electron Microsc; 2002 Jun; 35(2):87-95. PubMed ID: 12181650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney.
    Ha H; Lee HB
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S7-10. PubMed ID: 16174288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
    Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
    Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease.
    Ziyadeh FN
    Miner Electrolyte Metab; 1995; 21(4-5):292-302. PubMed ID: 7565478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitium.
    Levin A; Reznichenko A; Witasp A; Liu P; Greasley PJ; Sorrentino A; Blondal T; Zambrano S; Nordström J; Bruchfeld A; Barany P; Ebefors K; Erlandsson F; Patrakka J; Stenvinkel P; Nyström J; Wernerson A
    Nephrol Dial Transplant; 2020 Dec; 35(12):2059-2072. PubMed ID: 32853351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms.
    Wolf G; Ziyadeh FN
    Am J Kidney Dis; 1997 Jan; 29(1):153-63. PubMed ID: 9002545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy.
    Wang S; Chen Q; Simon TC; Strebeck F; Chaudhary L; Morrissey J; Liapis H; Klahr S; Hruska KA
    Kidney Int; 2003 Jun; 63(6):2037-49. PubMed ID: 12753291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.
    Soler MJ; Wysocki J; Ye M; Lloveras J; Kanwar Y; Batlle D
    Kidney Int; 2007 Sep; 72(5):614-23. PubMed ID: 17579661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats.
    Reddi AS; Bollineni JS
    Kidney Int; 2001 Apr; 59(4):1342-53. PubMed ID: 11260395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
    Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.
    Kato S; Luyckx VA; Ots M; Lee KW; Ziai F; Troy JL; Brenner BM; MacKenzie HS
    Kidney Int; 1999 Sep; 56(3):1037-48. PubMed ID: 10469372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polarity of stimulation and secretion of transforming growth factor-beta 1 by cultured proximal tubular cells.
    Phillips AO; Steadman R; Morrisey K; Williams JD
    Am J Pathol; 1997 Mar; 150(3):1101-11. PubMed ID: 9060845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.